ECHA Under the Microscope, While Yeast Learns to Make Its Own Bioethanol Enzymes
This week in the chemical industry brings a clash of two very different stories: a scathing audit of Europe's chemical safety oversight, and a promising breakthrough in industrial biotechnology. We look at why NGOs are pulling no punches with ECHA, and how modified yeast could cut the cost of bioethanol production.
01 · Law & Regulation
Ten Charges Against ECHA – the REACH System Under Fire [1]
ECHA — the European Chemicals Agency — has for years been a pillar of the REACH system, the EU regulations governing the registration, evaluation and authorization of chemical substances. That makes the latest list of grievances, published by a coalition of NGOs including ClientEarth, the European Environmental Bureau and Transparency International EU, land all the harder.
The report lays out ten points of criticism, and the numbers on the quality of the documentation itself are the most striking. As many as 70-80% of registration dossiers have significant gaps, mainly in data on health and environmental hazards. The picture is even worse when it comes to so-called intermediate substances - in 86% of the cases reviewed, companies were unable to reasonably demonstrate that a given substance actually serves that function, which matters for the scope of registration obligations.
The report's authors also point to chronically slow procedures - restrictions on the most hazardous substances can take more than a decade to come into force, and the European Commission routinely misses its statutory deadlines for issuing decisions. Just as serious is the allegation of conflicts of interest - according to the organizations, the same consultants who advise ECHA also work for industry groups lobbying against restrictions on PFAS substances. On top of that, there's poor transparency around the models used to estimate workers' occupational exposure.
For companies in the chemical, process automation or construction chemicals sectors, this is a signal that the foundations of the system underpinning their compliance procedures still have serious cracks - and the pressure to fix them is more likely to grow than fade.
02 · Biotechnology
Yeast That Makes Its Own Enzymes – Cheaper Bioethanol from Biomass [2]
From regulatory headaches, we move to a far more upbeat story - this time from the biotech lab bench. A team from Ghent University, working with the company NovelYeast, has developed a genetically modified strain of Saccharomyces cerevisiae yeast, named Cellusec, that secretes its own cellulase enzymes needed to break down lignocellulosic biomass - including forestry waste and wood.
That's a major shift from the conventional process, in which expensive enzymes have to be added externally. By inserting genes coding for several types of cellulase directly into the yeast, the need for commercial enzyme preparations dropped by as much as 53%. At the same time, ethanol production yield from forestry waste rose by 25% compared with unmodified strains.
It's a step toward so-called consolidated bioprocessing (CBP) - an approach in which a single microorganism both produces the enzymes that break down biomass and ferments the released sugars into ethanol, without a separate step or a separate enzyme supplier. For the biofuels sector and biomass-based chemistry, this could be one of the more important factors bringing these technologies closer to market viability, since the cost of enzymes has long been one of the main barriers.
Summary
Summary
This week shows two sides of the same industry: on one hand, a regulatory system that, despite good intentions, is still struggling with data quality and the pace of its own procedures; on the other, labs that are delivering real cuts to industrial production costs through small, concrete improvements. These two realities - regulatory and technological - will come together at ChemTEC Poland, where visitors can talk directly with experts and technology providers about REACH compliance, the quality of chemical substance documentation, and cutting-edge biotech solutions for the chemical industry and biofuel production. See you there!
Invitation
Regulatory topics around REACH and ECHA, along with biotech innovations like the Cellusec yeast strain, are part of everyday life in an industry we meet year after year at ChemTEC Poland. Visit the booths of providers of process technology, lab equipment and industrial biotechnology solutions, talk to chemical compliance experts, and see firsthand the innovations reshaping bioethanol and chemical production. Book your spot today - this is where regulation meets real-world solutions.
ChemTEC Poland 2026Footnotes
[1] Chemia i Biznes — https://www.chemiaibiznes.com.pl/artykuly/10-spraw-za-ktore-krytykowana-jest-europejska-agencja-chemikaliow[2] Bioengineer.org — https://bioengineer.org/engineered-cellulase-secreting-yeast-slashes-enzyme-costs-in-bioethanol-production/